表紙:コンパニオン診断の世界市場-製品およびサービス別・技術別・適応疾患別・エンドユーザー別・アプリケーション別・地域別:競争、予測および機会(2026年)SALE
市場調査レポート
商品コード
1030964

コンパニオン診断の世界市場-製品およびサービス別・技術別・適応疾患別・エンドユーザー別・アプリケーション別・地域別:競争、予測および機会(2026年)

Global Companion Diagnostic Market, By Products and Services, By Technology, By Disease Indication, By End-User, By Application, By Region, Competition Forecast & Opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.03円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

コンパニオン診断の世界市場-製品およびサービス別・技術別・適応疾患別・エンドユーザー別・アプリケーション別・地域別:競争、予測および機会(2026年)
出版日: 2021年10月01日
発行: TechSci Research
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
2021年12月末までSingle User Licenseのディスカウントキャンペーンを実施中です。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のコンパニオン診断市場規模は、2026年には387億9,000万米ドルに達するとみられ、予測期間中に11.13%のCAGRで成長すると予測されています。

コンパニオン診断市場が成長する主な要因は、世界的にがんの症例が増加していることが挙げられます。また、標的治療の必要性が高まっていることも、今後数年間のコンパニオン診断市場の成長に有利に働くと予想される主な要因となります。さらに、臨床試験の数が増加していることも、2026年までの市場の成長を後押しすると予想されます。

当レポートでは、世界のコンパニオン診断市場について調査しており、顧客の声、市場の見通し、市場力学、競合情勢など、包括的な情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 世界のコンパニオン診断市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

  • コンパニオン診断市場を推進する要因
  • ブランド認知度
  • 顧客満足度分析

第6章 世界のコンパニオン診断市場の見通し

  • 市場規模と予測
    • 価値別
  • 市場シェアと予測
    • 製品およびサービス別(キットおよび試薬、アッセイ、ソフトウェア、サービス)
    • 技術別(ポリメラーゼ連鎖反応(PCR)、次世代シーケンシング(NGS)、In-Situハイブリダイゼーション、免疫組織化学、その他)
    • 適応疾患別(腫瘍学、神経学、心臓病学、感染症、その他)
    • エンドユーザー別(製薬およびバイオテクノロジー企業、調査、委託調査機関、その他)
    • アプリケーション別(体外診断、創薬、その他)
    • 企業別(2020年)
    • 地域別
  • 製品市場マップ

第7章 北米のコンパニオン診断市場の見通し

  • 市場規模と予測
    • 価値別
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 適応疾患別
    • エンドユーザー別
    • アプリケーション別
    • 国別
  • 北米:国別分析
    • 米国のコンパニオン診断市場の見通し
    • カナダのコンパニオン診断市場の見通し
    • メキシコのコンパニオン診断市場の見通し

第8章 欧州のコンパニオン診断市場の見通し

  • 市場規模と予測
    • 価値別
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 適応疾患別
    • エンドユーザー別
    • アプリケーション別
    • 国別
  • 欧州:国別分析
    • ドイツのコンパニオン診断市場の見通し
    • 英国のコンパニオン診断市場の見通し
    • フランスのコンパニオン診断市場の見通し
    • イタリアのコンパニオン診断市場の見通し
    • スペインのコンパニオン診断市場の見通し

第9章 アジア太平洋のコンパニオン診断市場の見通し

  • 市場規模と予測
    • 価値別
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 適応疾患別
    • エンドユーザー別
    • アプリケーション別
    • 国別
  • アジア太平洋:国別分析
    • 中国のコンパニオン診断市場の見通し
    • 日本のコンパニオン診断市場の見通し
    • インドのコンパニオン診断市場の見通し
    • 韓国のコンパニオン診断市場の見通し
    • オーストラリアのコンパニオン診断市場の見通し
    • シンガポールのコンパニオン診断市場の見通し

第10章 南米のコンパニオン診断市場の見通し

  • 市場規模と予測
    • 価値別
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 適応疾患別
    • エンドユーザー別
    • アプリケーション別
    • 国別
  • 南米:国別分析
    • ブラジルのコンパニオン診断市場の見通し
    • アルゼンチンのコンパニオン診断市場の見通し
    • コロンビアのコンパニオン診断市場の見通し

第11章 中東およびアフリカのコンパニオン診断市場の見通し

  • 市場規模と予測
    • 価値別
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 適応疾患別
    • エンドユーザー別
    • アプリケーション別
    • 国別
  • 中東およびアフリカ:国別分析
    • 南アフリカのコンパニオン診断市場の見通し
    • サウジアラビアのコンパニオン診断市場の見通し
    • アラブ首長国連邦のコンパニオン診断市場の見通し

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と展開

第14章 競合情勢

  • 競合の見通し
  • 企業プロファイル(大手企業)
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Bayer AG
    • Quest Diagnostics Inc.
    • Danaher Corporation
    • Qiagen NV
    • Seimens Healthineers AG
    • F. Hoffmann-La Roche AG
    • Agilent Technologies Inc.
    • Abbott Laboratories Inc.
    • DiaSorin SpA(Luminex Corporation)
    • Icon Plc(MolecularMD Corporation)
    • Myriad Genetics Inc.
    • Biogenex Laboratories Inc.
    • bioMerieux SA

第15章 戦略的推奨事項

第16章 当社について・免責事項

図表

List of Figures

  • Figure 1: Global Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Companion Diagnostic Market Share, By Products and Services, By Value, By Value, 2016-2026F
  • Figure 3: Global Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 4: Global Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 5: Global Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 6: Global Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 7: Global Companion Diagnostic Market Share, By Company, By Value, 2020
  • Figure 8: Global Companion Diagnostic Market Share, By Region, By Value, 2016-2026F
  • Figure 9: Global Companion Diagnostic Product Market Map, By Value, 2016-2026F
  • Figure 10: North America Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 11: North America Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 12: North America Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 13: North America Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 14: North America Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 15: North America Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 16: North America Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
  • Figure 17: United States Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 18: United States Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 19: United States Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 20: United States Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 21: United States Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 22: United States Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 23: Canada Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 24: Canada Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 25: Canada Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 26: Canada Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 27: Canada Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 28: Canada Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 29: Mexico Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 30: Mexico Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 31: Mexico Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 32: Mexico Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 33: Mexico Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 34: Mexico Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 35: Europe Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 36: Europe Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 37: Europe Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 38: Europe Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 39: Europe Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 40: Europe Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 41: Europe Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
  • Figure 42: Germany Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 43: Germany Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 44: Germany Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 45: Germany Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 46: Germany Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 47: Germany Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 48: United Kingdom Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 49: United Kingdom Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 50: United Kingdom Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 51: United Kingdom Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 52: United Kingdom Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 53: United Kingdom Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 54: France Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 55: France Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 56: France Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 57: France Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 58: France Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 59: France Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 60: Italy Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 61: Italy Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 62: Italy Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 63: Italy Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 64: Italy Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 65: Italy Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 66: Spain Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 67: Spain Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 68: Spain Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 69: Spain Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 70: Spain Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 71: Spain Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 72: Asia-Pacific Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 73: Asia-Pacific Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 74: Asia-Pacific Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 75: Asia-Pacific Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 76: Asia-Pacific Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 77: Asia-Pacific Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 78: Asia-Pacific Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
  • Figure 79: China Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 80: China Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 81: China Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 82: China Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 83: China Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 84: China Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 85: Japan Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 86: Japan Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 87: Japan Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 88: Japan Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 89: Japan Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 90: Japan Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 91: India Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 92: India Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 93: India Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 94: India Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 95: India Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 96: India Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 97: South Korea Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 98: South Korea Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 99: South Korea Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 100: South Korea Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 101: South Korea Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 102: South Korea Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 103: Australia Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 104: Australia Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 105: Australia Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 106: Australia Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 107: Australia Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 108: Australia Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 109: Singapore Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 110: Singapore Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 111: Singapore Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 112: Singapore Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 113: Singapore Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 114: Singapore Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 115: South America Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 116: South America Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 117: South America Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 118: South America Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 119: South America Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 120: South America Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 121: South America Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
  • Figure 122: Brazil Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 123: Brazil Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 124: Brazil Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 125: Brazil Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 126: Brazil Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 127: Brazil Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 128: Argentina Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 129: Argentina Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 130: Argentina Companion Diagnostic Market Share, By Technology, By Value, 2016-2026
  • Figure 131: Argentina Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 132: Argentina Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 133: Argentina Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 134: Colombia Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 135: Colombia Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 136: Colombia Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 137: Colombia Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 138: Colombia Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 139: Colombia Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 140: Middle East and Africa Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 141: Middle East and Africa Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 142: Middle East and Africa Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 143: Middle East and Africa Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 144: Middle East and Africa Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 145: Middle East and Africa Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 146: Middle East and Africa Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
  • Figure 147: South Africa Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 148: South Africa Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 149: South Africa Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 150: South Africa Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 151: South Africa Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 152: South Africa Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 153: Saudi Arabia Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 154: Saudi Arabia Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 155: Saudi Arabia Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 156: Saudi Arabia Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 157: Saudi Arabia Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 158: Saudi Arabia Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
  • Figure 159: UAE Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
  • Figure 160: UAE Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 161: UAE Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
  • Figure 162: UAE Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
  • Figure 163: UAE Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
  • Figure 164: UAE Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
目次
Product Code: 4536

Global companion diagnostic market is expected to reach USD38.79 billion by 2026, growing at double-digit CAGR of 11.13% over the forecast period. The key factor responsible for the growth of companion diagnostic market is the growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2026.

Global companion diagnostic market is segmented based on products and services, technology, disease indication, end-user, application, company, and region. The market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization, and others based on end-user. Out of these, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2020 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well. This growth can be accredited to the widespread use of companion diagnostics in such industries because of their increasing stronghold in the drug development sector as well as the growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with high demand for targeted therapies for the treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the global companion diagnostic market include Thermo Fisher Scientific Inc., Illumina Inc., Bayer AG, Quest Diagnostics Inc., Danaher Corporation, Qiagen NV, Seimens Healthineers AG, F. Hoffmann-La Roche AG, Agilent Technologies Inc., Abbott Laboratories Inc., DiaSorin SpA (Luminex Corporation), Icon Plc (MolecularMD Corporation), Myriad Genetics Inc., Biogenex Laboratories Inc., bioMerieux SA and others. The companies operating in the global companion diagnostic market are focusing on expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of global companion diagnostic market from 2016 to 2020.
  • To estimate and forecast the market size of global companion diagnostic market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global companion diagnostic market based on products and services, technology, disease indication, end-user, application, company and region.
  • To identify drivers and challenges for global companion diagnostic market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global companion diagnostic market.
  • To conduct pricing analysis for global companion diagnostic market.
  • To identify and analyse the profile of leading players operating in global companion diagnostic market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, technologies and presence of all major players across the globe.

TechSci Research calculated the market size of global companion diagnostic market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Companion diagnostic hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to companion diagnostic
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global companion diagnostic market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Companion Diagnostic Market, By Products and Services:

Kits and Reagents

Assays

Software and Services

  • Global Companion Diagnostic Market, By Technology:

Polymerase Chain Reaction (PCR)

Next Generation Sequencing (NGS)

In-situ Hybridization

Immunohistochemistry

Others

  • Global Companion Diagnostic Market, By Disease Indication:

Oncology

Neurology

Cardiology

Infectious Diseases

Others

  • Global Companion Diagnostic Market, By End-User:

Pharmaceutical & Biotechnology Companies

Research Laboratories

Contract research organization

Others

  • Global Companion Diagnostic Market, By Application:

In-Vitro diagnostics

Drug Discovery

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore

South America

  • Brazil
  • Argentina
  • Colombia

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global companion diagnostic market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Companion Diagnostic Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Factors Driving the Companion Diagnostic Market
  • 5.2. Brand Awareness
  • 5.3. Customer Satisfaction Analysis

6. Global Companion Diagnostic Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products and Services (Kits and Reagents, Assays, Software and Services)
    • 6.2.2. By Technology (Polymerase Chain Reaction (PCR), Next-Generation sequencing (NGS), In-Situ Hybridization, Immunohistochemistry and Others)
    • 6.2.3. By Disease Indication (Oncology, Neurology, Cardiology, Infectious Diseases and Others)
    • 6.2.4. By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract Research Organization and Others)
    • 6.2.5. By Application (In-Vitro Diagnostics, Drug Discovery and Others)
    • 6.2.6. By Company (2020)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. North America Companion Diagnostic Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products and Services
    • 7.2.2. By Technology
    • 7.2.3. By Disease Indication
    • 7.2.4. By End User
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Companion Diagnostic Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products and Services
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Disease Indication
        • 7.3.1.2.4. By End User
        • 7.3.1.2.5. By Application
    • 7.3.2. Canada Companion Diagnostic Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products and Services
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Disease Indication
        • 7.3.2.2.4. By End User
        • 7.3.2.2.5. By Application
    • 7.3.3. Mexico Companion Diagnostic Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products and Services
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Disease Indication
        • 7.3.3.2.4. By End User
        • 7.3.3.2.5. By Application

8. Europe Companion Diagnostic Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products and Services
    • 8.2.2. By Technology
    • 8.2.3. By Disease Indication
    • 8.2.4. By End User
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Companion Diagnostic Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products and Services
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Disease Indication
        • 8.3.1.2.4. By End User
        • 8.3.1.2.5. By Application
    • 8.3.2. United Kingdom Companion Diagnostic Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products and Services
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Disease Indication
        • 8.3.2.2.4. By End User
        • 8.3.2.2.5. By Application
    • 8.3.3. France Companion Diagnostic Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products and Services
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Disease Indication
        • 8.3.3.2.4. By End User
        • 8.3.3.2.5. By Application
    • 8.3.4. Italy Companion Diagnostic Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products and Services
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Disease Indication
        • 8.3.4.2.4. By End User
        • 8.3.4.2.5. By Application
    • 8.3.5. Spain Companion Diagnostic Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products and Services
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Disease Indication
        • 8.3.5.2.4. By End User
        • 8.3.5.2.5. By Application

9. Asia-Pacific Companion Diagnostic Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products and Services
    • 9.2.2. By Technology
    • 9.2.3. By Disease Indication
    • 9.2.4. By End User
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Companion Diagnostic Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products and Services
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Disease Indication
        • 9.3.1.2.4. By End User
        • 9.3.1.2.5. By Application
    • 9.3.2. Japan Companion Diagnostic Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products and Services
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Disease Indication
        • 9.3.2.2.4. By End User
        • 9.3.2.2.5. By Application
    • 9.3.3. India Companion Diagnostic Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products and Services
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Disease Indication
        • 9.3.3.2.4. By End User
        • 9.3.3.2.5. By Application
    • 9.3.4. South Korea Companion Diagnostic Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Products and Services
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Disease Indication
        • 9.3.4.2.4. By End User
        • 9.3.4.2.5. By Application
    • 9.3.5. Australia Companion Diagnostic Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Products and Services
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Disease Indication
        • 9.3.5.2.4. By End User
        • 9.3.5.2.5. By Application
    • 9.3.6. Singapore Companion Diagnostic Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Products and Services
        • 9.3.6.2.2. By Technology
        • 9.3.6.2.3. By Disease Indication
        • 9.3.6.2.4. By End User
        • 9.3.6.2.5. By Application

10. South America Companion Diagnostic Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products and Services
    • 10.2.2. By Technology
    • 10.2.3. By Disease Indication
    • 10.2.4. By End User
    • 10.2.5. By Application
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Companion Diagnostic Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products and Services
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Disease Indication
        • 10.3.1.2.4. By End User
        • 10.3.1.2.5. By Application
    • 10.3.2. Argentina Companion Diagnostic Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products and Services
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Disease Indication
        • 10.3.2.2.4. By End User
        • 10.3.2.2.5. By Application
    • 10.3.3. Colombia Companion Diagnostic Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products and Services
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Disease Indication
        • 10.3.3.2.4. By End User
        • 10.3.3.2.5. By Application

11. Middle East and Africa Companion Diagnostic Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Products and Services
    • 11.2.2. By Technology
    • 11.2.3. By Disease Indication
    • 11.2.4. By End User
    • 11.2.5. By Application
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Companion Diagnostic Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Products and Services
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Disease Indication
        • 11.3.1.2.4. By End User
        • 11.3.1.2.5. By Application
    • 11.3.2. Saudi Arabia Companion Diagnostic Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Products and Services
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Disease Indication
        • 11.3.2.2.4. By End User
        • 11.3.2.2.5. By Application
    • 11.3.3. UAE Companion Diagnostic Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Products and Services
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Disease Indication
        • 11.3.3.2.4. By End User
        • 11.3.3.2.5. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Thermo Fisher Scientific Inc.
    • 14.2.2. Illumina Inc.
    • 14.2.3. Bayer AG
    • 14.2.4. Quest Diagnostics Inc.
    • 14.2.5. Danaher Corporation
    • 14.2.6. Qiagen NV
    • 14.2.7. Seimens Healthineers AG
    • 14.2.8. F. Hoffmann-La Roche AG
    • 14.2.9. Agilent Technologies Inc.
    • 14.2.10. Abbott Laboratories Inc.
    • 14.2.11. DiaSorin SpA (Luminex Corporation)
    • 14.2.12. Icon Plc (MolecularMD Corporation)
    • 14.2.13. Myriad Genetics Inc.
    • 14.2.14. Biogenex Laboratories Inc.
    • 14.2.15. bioMerieux SA

15. Strategic Recommendations

16. About Us & Disclaimer